FDA approves second infusible anti–tumor necrosis factor treatment for patients with moderate to severe rheumatoid arthritis. (posted Aug. 16, 2013)
American College of Rheumatology Backs Bill to Prevent Cuts to Infusion Reimbursement
The ACR has endorsed a proposed law that would exempt physician-administered drugs from future Medicare sequestration. (posted Aug. 21, 2013)
When Will Generic Biologic Drugs Become Commercially Available?
Biosimilars are challenging to produce, but progress is being made
ACR 2013 State-of-the-Art Clinical Symposium: The Challenge of Treating Low Back Pain
With no single therapy effective for chronic low back pain, physicians must try multiple therapeutic approaches, nonsurgical options
Rheumatology Circuit Brings Healthcare to Small Towns
Circuit-riding physicians go from hospital to hospital providing specialty services to rheumatology patients in rural areas
President’s Perspective: The ACR and ARHP Advance Rheumatology Through International Collaboration
By forging new connections and strengthening efforts with global organizations such as EULAR, the College hopes to enhance the science, clinical care, and perceived value of rheumatology
Rheuminations: How Tiny Ticks Have Fueled Outrage and Acrimony in Some Communities
A history of rheumatologists’ efforts to diagnose Lyme disease
Speak Out Rheum: Fifty Years of APLAR
A past president reminisces about the formation and history of the Asia Pacific League of Associations for Rheumatology on its 50th anniversary
Meet the Challenges of Measuring Outcomes in Rheumatology Clinical Practice
Clinicians and researchers will discuss the latest trends in assessing patient-reported outcomes in the premeeting Clinical Focus Course at this year’s ACR/ARHP Annual Meeting
The Pharmacist’s Role in Managing Rheumatic Diseases
An overview of the many benefits pharmacists can bring to a multidisciplinary healthcare team
- « Previous Page
- 1
- …
- 647
- 648
- 649
- 650
- 651
- …
- 816
- Next Page »